iShares Biotechnology ETF (NASDAQ:IBB) Position Cut by RS Crum Inc.

RS Crum Inc. trimmed its holdings in iShares Biotechnology ETF (NASDAQ:IBB) by 1.3% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 9,656 shares of the financial services provider’s stock after selling 127 shares during the quarter. RS Crum Inc.’s holdings in iShares Biotechnology ETF were worth $1,406,000 at the end of the most recent reporting period.

Other institutional investors also recently added to or reduced their stakes in the company. Townsquare Capital LLC raised its position in shares of iShares Biotechnology ETF by 10.1% during the 3rd quarter. Townsquare Capital LLC now owns 1,683 shares of the financial services provider’s stock worth $245,000 after buying an additional 154 shares in the last quarter. BNP Paribas Financial Markets increased its stake in shares of iShares Biotechnology ETF by 29.3% during the third quarter. BNP Paribas Financial Markets now owns 2,380,229 shares of the financial services provider’s stock valued at $346,561,000 after acquiring an additional 538,899 shares during the period. FMR LLC raised its holdings in iShares Biotechnology ETF by 19.2% during the third quarter. FMR LLC now owns 14,450 shares of the financial services provider’s stock worth $2,104,000 after purchasing an additional 2,332 shares in the last quarter. Associated Banc Corp lifted its position in iShares Biotechnology ETF by 5.7% in the third quarter. Associated Banc Corp now owns 44,976 shares of the financial services provider’s stock worth $6,549,000 after purchasing an additional 2,425 shares during the period. Finally, Brown Brothers Harriman & Co. boosted its stake in iShares Biotechnology ETF by 40,000.0% during the 3rd quarter. Brown Brothers Harriman & Co. now owns 11,228 shares of the financial services provider’s stock valued at $1,635,000 after purchasing an additional 11,200 shares in the last quarter. Institutional investors and hedge funds own 62.45% of the company’s stock.

iShares Biotechnology ETF Trading Up 0.2 %

Shares of IBB stock opened at $140.23 on Wednesday. iShares Biotechnology ETF has a 1 year low of $117.28 and a 1 year high of $150.57. The business’s fifty day moving average is $143.27 and its 200-day moving average is $141.92.

iShares Biotechnology ETF Dividend Announcement

The company also recently announced a dividend, which was paid on Monday, September 30th. Investors of record on Wednesday, September 25th were issued a dividend of $0.2005 per share. The ex-dividend date of this dividend was Wednesday, September 25th.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.